News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

bioTheranostics Appoints Three Key Executives


8/27/2013 6:32:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

bioTheranostics, Inc., a leading provider of molecular diagnostic solutions for metastatic cancer, today announced the addition of three industry veterans to its senior management team as it prepares for further commercial expansion and launch of its Breast Cancer IndexSM (BCI) molecular test. Gail Sloan joins the company as chief financial officer, Macey Johnson, III, as vice president of managed care and reimbursement, and Matt Sargent as Breast Cancer Index commercialization leader.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES